Honduras Pharmaceuticals and Healthcare Report Q2 2016
BMI View: Over the next ten years, there will be limited demand for advanced medicines within Honduras’
public healthcare system. Low-cost generic drugs will continue to dominate the local market. The
pharmaceutical market in Honduras will continue to be extremely unattractive to multinational drugmakers
due to the small market size, low growth rate and the fragmented, opaque and often-questionable public
procurement process.
Headline Expenditure Projections
Pharmaceuticals: HNL10.33bn (USDb473mn) in 2015 to HNL10.70bn (USD480mn) in 2016; +3.5% in
local currency terms, and +1.0% in US dollar terms. Our forecast has not changed since Q215.
Healthcare: HNL37.83bn (USDb1.73bn) in 2015 to HNL40.95bn (USD1.83n) in 2016; +8.3% in local
currency terms, and +5.6% in US dollar terms. Our forecast has been revised downwards since Q415 due to
revised macroeconomic data.
BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Honduras 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Honduras 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Honduras 2012-2020) 15
Industry Risk/Reward Index 16
Americas Risk/Reward Index 16
Industry Risk/Reward Index 22
Rewards 22
Risks 22
Regulatory Review 24
Market Overview 25
Healthcare Sector 25
Clinical Trials 29
Epidemiology 29
Competitive Landscape 32
Demographic Forecast 33
Demographic Outlook 33
Table: Population Headline Indicators (Honduras 1990-2025) 34
Table: Key Population Ratios (Honduras 1990-2025) 34
Table: Urban/Rural Population & Life Expectancy (Honduras 1990-2025) 35
Table: Population By Age Group (Honduras 1990-2025) 35
Table: Population By Age Group % (Honduras 1990-2025) 36
Glossary 38
Methodology 40
Pharmaceutical Expenditure Forecast Model 40
Healthcare Expenditure Forecast Model 40
Notes On Methodology 41
Risk/Reward Index Methodology 42
Index Overview 43
Table: Pharmaceutical Risk/Reward Index Indicators 43
Indicator Weightings 44
List of Tables
Table: Headline Pharmaceuticals & Healthcare Forecasts (Honduras 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Honduras 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Honduras 2012-2020)
Table: Population Headline Indicators (Honduras 1990-2025)
Table: Key Population Ratios (Honduras 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Honduras 1990-2025)
Table: Population By Age Group (Honduras 1990-2025)
Table: Population By Age Group % (Honduras 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators